Last deal

$800K

Amount

Grant

Stage

21.06.2017

Date

2

all rounds

$800K

Total amount

date founded

Financing round

General

About Company
BioTherapeutics Inc. (BTI) develops small-molecule drugs for autoimmune and metabolic diseases.

Industry

Sector :

Subsector :

founded date

01.01.2008

Number of employees

Company Type

For Profit

Last funding type

Grant

IPO status

Private

Description

BTI is a science-based biotechnology company that integrates nutraceuticals, pharmaceuticals, and informatics to advance precision medicine. By combining advanced computational modeling, data analytics, and artificial intelligence with translational experimentations, BTI accelerates the development of innovative products for precision medicine and health. Their computational platform assembles biomedical and healthcare data from various levels and leverages the latest technology to provide solutions to complex biological questions and healthcare problems.
Contacts

Contact Email

Phone number

Social url

Similar Companies
1000
Exeliom

Exeliom

Exeliom is a clinical-stage biopharmaceutical company revolutionizing healthcare by using commensal bacteria as drugs.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

21000 Dijon, France

total rounds

5

total raised

$25.51M
Cytokinetics

Cytokinetics

Cytokinetics is a biopharmaceutical company focused on developing muscle-impacting therapeutics.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

South San Francisco, CA, USA

total rounds

11

total raised

$1.76B

count Of Investments

2
Kineta

Kineta

Kineta develops edge therapeutics for autoimmune disease, viral disease, and chronic pain.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Seattle, WA, USA

total rounds

21

total raised

$96.92M
NGM Biopharmaceuticals

NGM Biopharmaceuticals

NGM Biopharmaceuticals is developing novel therapeutics for cardio-metabolic, liver, oncologic and ophthalmic diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

South San Francisco, CA, USA

total rounds

7

total raised

$542.44M

Financials

Funding Rounds
2
2

Number of Funding Rounds

$800K

Money Raised

Their latest funding was raised on 21.06.2017. Their latest investor CIT GAP Funds. Their latest round Grant

Date 
Funding Round 
Investors 
Money Raised 
Lead 
Virginia Catalyst

Virginia Catalyst

Virginia Catalyst is a non-profit corporation that fosters economic development in Virginia's life sciences industry.

Sector

Medical Equipment and Services

Subsector

Medical Services

Keywords

Non-Profit, Government

Location

Richmond, VA, USA

count Of Investments

12
CIT GAP Funds

CIT GAP Funds

The Virginia Venture Capital Corporation (VVC) is a non-profit organization that drives innovation and entrepreneurship in Virginia.

Sector

Industrial Support Services

Subsector

Professional Business Support Services

Keywords

Non-Profit, Venture Capital, Financial Services

Location

Herndon, VA 20170, USA

count Of Investments

194

count Of Exists

36
Co-Investors
Investors
2
2

Number of lead investors

2

Number of investors

Investor 
Lead 
Round 
Partners 
Yes
Venture - Series Unknown
CIT GAP Funds

CIT GAP Funds

The Virginia Venture Capital Corporation (VVC) is a non-profit organization that drives innovation and entrepreneurship in Virginia.

Sector

Industrial Support Services

Subsector

Professional Business Support Services

Keywords

Non-Profit, Venture Capital, Financial Services

Location

Herndon, VA 20170, USA

count Of Investments

194

count Of Exists

36
Virginia Catalyst

Virginia Catalyst

Virginia Catalyst is a non-profit corporation that fosters economic development in Virginia's life sciences industry.

Sector

Medical Equipment and Services

Subsector

Medical Services

Keywords

Non-Profit, Government

Location

Richmond, VA, USA

count Of Investments

12

People

Founders
1
Josep Bassaganya-Riera
Josep Bassaganya-Riera

Josep Bassaganya-Riera

Josep Bassaganya-Riera is the current Executive Chairman of the Board, President, and CEO of Biotherapeutics Inc. He previously worked at Landos Biopharma, Inc. as a Chairman of the Board, President, and CEO. Josep Bassaganya-Riera attended Iowa State University.

current job

Landos Biopharma
Landos Biopharma

organization founded

2

Josep Bassaganya-Riera

Employee Profiles
8
Josep Bassaganya-Riera

Josep Bassaganya-Riera

President & CEO

Raquel Hontecillas

Raquel Hontecillas

Chief Scientific Officer

Activity

Recent News
1